<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">DEMECLOCYCLINE HYDROCHLORIDE</span><br/>(dem-e-kloe-sye'kleen)<br/><span class="topboxtradename">Declomycin<br/></span><b>Classifications:</b> <span class="classification">antiinfective</span>; <span class="classification">antibiotic</span>; <span class="classification">tetracycline</span><br/><b>Prototype: </b>Tetracycline<br/><b>Pregnancy Category: </b>D<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>150 mg capsules; 150 mg, 300 mg tablets</p>
<h1><a name="action">Actions</a></h1>
<p>Broad-spectrum, tetracycline antibiotic isolated from mutant strain of <i>Streptomyces aureofaciens</i>. Similar to tetracycline but is absorbed more readily, excreted much more slowly.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Drug has longer duration of effective blood levels than tetracycline; therefore intervals between doses can be longer. Primarily
         bacteriostatic in action.
      </p>
<h1><a name="uses">Uses</a></h1>
<p>Similar to those of tetracycline.</p>
<h1><a name="unlabeleduses">Unlabeled Uses</a></h1>
<p>Treatment of chronic SIADH [Syndrome of Inappropriate (excessive) Antidiuretic Hormone] secretion.</p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Hypersensitivity to any of the tetracyclines; cirrhosis, common bile duct obstruction; period of tooth development [last half
         of pregnancy (category D), lactation, children 
      </p><h1><a name="precaution">Cautious Use</a></h1>
<p>Impaired renal or hepatic function; nephrogenic diabetes insipidus; use of capsule or tablet formulations in patients with
         esophageal compression or obstruction.
      </p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Antiinfective</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 150 mg q6h or 300 mg q12h (max: 2.4 g/d)<br/><span class="rdage">Child:</span> <span class="rdroute">PO</span> &gt;<i>8 y</i>, 812 mg/kg/d divided q812h<br/><br/><span class="indicationtitle">Gonorrhea</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 600 mg followed by 300 mg q12h for 4 d<br/><br/><span class="indicationtitle">SIADH</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 6001200 mg/d in 34 divided doses<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li>Give not less than 1 h before or 2 h after meals. Foods rich in iron (e.g., red meat or dark green vegetables) or calcium
            (e.g., milk products) impair absorption.
         </li>
<li>Concomitant therapy: Do not give antacids with tetracyclines.</li>
<li>Check expiration date before giving drug. Renal damage and death have resulted from use of outdated tetracyclines.</li>
<li>Request physician order to give with light meal if gastric distress is a problem. Absorption may be reduced; keep meal dairy
            free.
         </li>
<li>Store in tight, light-resistant containers, preferably at 15°30° C (59°86° F) unless otherwise
            directed. Tetracyclines form toxic products when outdated or exposed to light, heat, or humidity.
         </li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead"> Body as a Whole:</span> Hypersensitivity [<span class="speceff-common">photosensitivity,</span>
<span class="speceff-life">pericarditis, anaphylaxis</span> (rare)]. <span class="typehead">GI:</span>
<span class="speceff-common">Nausea,</span> vomiting, <span class="speceff-common">diarrhea,</span> esophageal irritation or ulceration, enterocolitis, abdominal cramps, anorexia. <span class="typehead">Urogenital:</span> Diabetes insipidus, azotemia, hyperphosphatemia. <span class="typehead">Skin:</span> Pruritus, erythematous eruptions, exfoliative dermatitis. 
      <h1><a name="dtintefer">Diagnostic Test Interference</a></h1>
<p>Like other tetracyclines, demeclocycline may cause false increases in <span class="alt">urine catecholamines</span> (<b>fluorometric</b> methods); false decreases in <span class="alt">urine urobilinogen;</span> and false-negative <span class="alt">urine glucose</span> with <b>glucose oxidase</b> methods (e.g., <b>Clinistix, TesTape</b>).
      </p>
<h1><a name="interactions">Interactions</a></h1><span class="typehead"> Drug:</span>
<span class="classification"> antacids</span>, <span class="classification">iron preparation</span>, <b>calcium,</b>
<b>magnesium,</b>
<b>zinc,</b>
<b>kaolin-pectin,</b>
<b>sodium bicarbonate</b> can significantly decrease demeclocycline absorption; effects of <b>desmopressin</b> and demeclocycline antagonized; increases <b>digoxin</b> absorption, increasing risk of <b>digoxin</b> toxicity; <b>methoxyflurane</b> increases risk of renal failure. <span class="typehead">Food:</span> Dairy products significantly decrease demeclocycline absorption; food may decrease drug absorption also. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> 6080% absorbed from GI tract. <span class="typehead">Peak:</span> 34 h. <span class="typehead">Distribution:</span> Concentrated in liver; crosses placenta; distributed into breast milk. <span class="typehead">Metabolism:</span> Metabolized in liver; enterohepatic circulation. <span class="typehead">Elimination:</span> 4050% excreted in urine and 31% in feces in 48 h. <span class="typehead">Half-Life:</span> 1017 h. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Lab tests: C&amp;S prior to initial therapy and periodically during prolonged therapy. With prolonged therapy, add periodic evaluations
            of serum drug levels, electrolytes, and renal, hepatic, and hematopoietic systems.
         </li>
<li>Monitor I&amp;O ratio and pattern and record weights in patients with impaired kidney or liver function, or on prolonged or high
            dose therapy. Some patients develop diabetes insipidus-like syndrome (SIADH).
         </li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Do not use antacids while taking this drug.</li>
<li>Take drug on an empty stomach to enhance absorption. Because esophageal irritation and ulceration have been reported, take
            each dose with a full glass (240 mL) of water; remain upright for at least 90 s after taking medication; and avoid taking
            drug within 1 h of lying down or bedtime.
         </li>
<li>Notify physician if gastric distress is a problem; a snack or light meal free of dairy products may be added to the regimen.</li>
<li>Report symptoms of superinfections; this is VERY important (see Appendix F).</li>
<li>Demeclocycline-induced phototoxic reaction can be unusually severe. Avoid sunlight as much as possible and use sunscreen.</li>
<li>Do not breast feed while taking this drug.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>